Hemofiltration: The case for removal of sepsis mediators from where they do harm*
- 1 August 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 34 (8), 2244-2246
- https://doi.org/10.1097/01.ccm.0000227650.77064.5f
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure*Critical Care Medicine, 2006
- High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shockIntensive Care Medicine, 2006
- Hemofiltration for Cytokine-Driven Illnesses: The Mediator Delivery HypothesisThe International Journal of Artificial Organs, 2005
- Extracorporeal Blood Treatment (EBT) Methods in SIRS/SepsisThe International Journal of Artificial Organs, 2005
- High Volume Hemofiltration (HVHF) in Sepsis: A Comprehensive Review of Rationale, Clinical Applicability, Potential Indications and Recommendations for Future ResearchThe International Journal of Artificial Organs, 2004
- Cascade Filtration: A New Filter for Secondary Filtration – A Multicentric StudyThe International Journal of Artificial Organs, 2004
- Extracorporeal removal for sepsis: Acting at the tissue level—The beginning of a new era for this treatment modality in septic shock *Critical Care Medicine, 2004
- Impact of High Volume Hemofiltration on Hemodynamic Disturbance and Outcome during Septic ShockASAIO Journal, 2004
- Interpreting the Mechanisms of Continuous Renal Replacement Therapy in Sepsis: The Peak Concentration HypothesisArtificial Organs, 2003
- Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trialThe Lancet, 2000